News Article

On October 25^th, Womble Carlyle hosted a licensing panel for the Bay Area In-House Medtech Attorneys (BAIMA) at the Four Seasons Hotel in Palo Alto, California. Christopher E. Jeffers, Ph.D. moderated the panel entitled "Medical Device Licensing: Fundamentals of Deal Structure and Terms and Analysis of Recent Deals." The panel discussed the overall M&A “climate” for medical devices, what "big device" is looking for in an acquisition target, and an update on deal trends. Madeline I. Johnston, Ph.D., in the firm’s Silicon Valley office, organized the event. 

 

Panelists included: Eb Bright, Executive Vice President & General Counsel, ExploraMed Development, LLC; Jeff Grainger, Partner, The Foundry; Angela McFarlane, CEO, ForSight; Karun Naga, Director, Corporate Development, Medtronic; and Freddie Park, VP, Legal Affairs, Merz Aesthetics, Inc.

 

Chris Jeffers is a registered patent attorney and member of the Chemical / Pharmaceutical / Biotechnology Patent Team of Womble Carlyle's Intellectual Property Practice Group. Jeffers focuses his practice on the representation of life sciences, biotechnology and medical device companies in the areas of complex IP transactions, licensing, patent prosecution and litigation.

 

Madeline Johnston is also a registered patent attorney and member of the Chemical / Pharmaceutical / Biotechnology Patent Team of Womble Carlyle's IP Practice Group. She has experience in a variety of technology areas including pharmaceuticals, cell biology, immunology, vaccines, nucleic acids, polymers, medical devices, adhesives, batteries and semiconductors. She works with clients on life cycle patent strategy at all stages of drug development.